Jim Clifton is Chief Operating Officer of Bluegrass Vascular Technologies (BVT). Jim joined BVT as Founder and Chief Executive Officer in February 2011, when the company was spun out of Therix Medical Development, a private incubator established to commercialize technologies from the University of Kentucky. In 2009, Jim helped found and served as CEO of Therix Medical. He held both CEO positions simultaneously while spending the majority of his time launching BVT. BVT was seed funded by Therix and Jim raised additional funds in 2012 to complete the first-in-human study in South America and the Series A in 2014. For the past 20 plus years, Jim has been in and around early stage technology development, working with founders and managing early stage investments.
Bluegrass Vascular Technologies
Chief Operating Officer